Navigation Links
Global Fund Policy Encouraging Drug Resistance

WHO has warned Global Fund, the world's leading funder of treatments for infectious disease, that its current policy of Treating AIDS, Tuberculosis and Malaria// carried a risk of causing drug resistance.

Kochi Arata, head of the WHO's malaria programme referring to the compliance list of drugs circulated by the Global Fund which contains advice on the malaria drug artemisinin. It has been found that Artemisinin was effective in treating the worst cases of malaria even the strains of the malarial parasite that had developed resistance to all other drugs.

However as health experts warn the use of this drug as a ‘monotherapy’, that is without a second drug, would foster resistance, leaving no alternative medicine to treat the resistant parasite.

The Global Fund's compliance list cites several such monotherapies where the manufacturing is of good quality and is used as a guide for countries purchasing these malaria drugs. WHO had launched an appeal to stop monotherapy, urging manufacturers to stop producing artemisinin alone, and on countries to ban its use.13 of the 40 manufacturers of artemisinin therapy that the WHO identified have agreed to cease its production.

Mr Arata expressed concerns that others might seek to exploit the gap created by the Global Fund's compliance list and boost their own monotherapy sales. Although several countries have also agreed to withdraw marketing authorisation from monotherapies to ban their use, 49 have not.

According to him China both uses and produces large amounts of artemisinin which was a major issue of concern. In addition Mr Arata criticised the 'unsatisfactory' response of the Global Fund to the WHO's demands that it change its compliance list.

Global Fund has defended themselves claiming that they would follow whatever advice the WHO gave to countries it funded. However it argued that its list was not compulsory and only reflected the guidelines of the WHO. WHO does
'"/>




Page: 1 2

Related medicine news :

1. SARS-Free Taiwan to Mark End Phase of Global Fight
2. Prevent Global Warming by Becoming A Vegetarian
3. India To March Ahead in The Global HealthCare Competition
4. Global Outbreak Of Bird Flu Warning By Chinese Scientist
5. TWO India Doctors Listed in TIME for Contribution to Global Health
6. Global Hospitals coming to city of Joy
7. John Hopkins CGHH program provides Global Health education
8. Ban on Global fund lifted in Uganda
9. Global Warming Could Cause 5 Million Illnesses: WHO
10. Global Health Bonds to Improve Health Care Facilities for the Underprivileged.
11. Skin Cancer Research To Go Global

Post Your Comments:
(Date:11/8/2009)... A jury of 8 people in the Western Dist...$2,300,000 in pain and suffering for a medical mal...llman and Alicia Nocera of Thomas E. Crenney and A...laintiff, Vita Monestersky and against the Unionto...otal abdominal hysterectomy at age 18. , ...
(Date:11/8/2009)...ON, Nov. 7 USAction thi...Care for America Act, which will make health care ...anies accountable and increase access to health ca...on. ,, "Teddy Roosevelt, FDR and Harry Truman w...n Charney. "Today,s vote ranks among our country,s...
(Date:11/8/2009)...aises House Passage of Health Care Reform Bill ,...e, improve coverage for all Americans ,, CHICA...nited States House of Representatives passed by a ...lation that would strengthen Medicare for seniors ... prices millions of Americans out of affordable he...
(Date:11/7/2009)...ON, Nov. 7 Karen Ignagn... Plans (AHIP), released the following statement to...lans strongly support comprehensive health care re...y proposing a complete overhaul of how health insu...guaranteed coverage, elimination of pre-existing c...
(Date:11/7/2009)...yn T. Coleman (CT), David A. Cook (GA), Louis J. G... (LA) Honored ,, CHICAGO, Nov. 7 /PRNewswire-U...A) today presented five medical society executive ...tributions to the goals and ideals of the medical ... semi-annual policy making meeting in Houston. ,...
Breaking Medicine News(10 mins):Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA Honors Medical Society Executives 2
...alue to Retirees, Working Families, and Communitie...ns, the,value of their Social Security is the bigg...tirement. In fact, for two-thirds of recipients ov...tional Academy of Social Insurance (NASI)., The r...
...1 Presidential,candidates, federal and state poli...be watching closely over the next year to gauge th...form efforts, especially in states,like Massachuse...lan,is certain to garner more attention this sprin...
...ientists and the Food and Drug Administration (FDA...logy, which make it possible to collect better dat...clinical trials requirements. , Researchers from ... representatives before an audience of their peers...
...an. 31 BioForm Medical,Inc. (Nasdaq: BFRM ) toda...ended December 31, 2007, which is the Company,s se...18.6 million for the quarter ended December 31,200...rter ended December 31, 2007 as compared to $2.7 m...
...are company expands AmeriHealth Mercy,s product ...care, PHILADELPHIA, Jan. 31 The AmeriHealth Merc... care company, announced today that,it has acquire...nsylvania. CBHNP, now a wholly owned subsidiary of...
... Vulnerable Seniors, Nursing Home Care to Face,Sev...on a New,York Times article today reporting the Bu...are-financed nursing home care in his FY 2009 budg...,Coalition was active at the state and national le...
Other Medicine News:Health News:Social Security Is Worth $225,000 for a Typical Retiree 2Health News:Social Security Is Worth $225,000 for a Typical Retiree 3Health News:Survey: Massachusetts Employers, Employees Paying Most for Health Care Plans 2Health News:Survey: Massachusetts Employers, Employees Paying Most for Health Care Plans 3Health News:Researchers query FDA about updating requirements for drug approval 2Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 2Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 3Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 4Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 5Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 6Health News:BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008 7Health News:AmeriHealth Mercy Family of Companies Acquires Community Behavioral HealthCare Network of Pennsylvania 2Health News:Coalition to Protect Senior Care Gearing Up to Fight Bush Administration Medicare Cuts 2
(Date:11/6/2009)...wire-FirstCall/ -- Caraco Pharmaceutical Laborator...c tromethamine ophthalmic solution, 0.5% following...stration (FDA) for Sun Pharma,s Abbreviated New Dr...thalmic solution on the first day following patent...utically equivalent to Acular® Ophthalmic Sol...
(Date:11/6/2009)... Derma Sciences, Inc. ...ed wound care products, announced plans to release...onday, November 16, 2009. The Company will hold a ...ts at 11:00 am EST. Interested parties should call...rnational), with passcode 81416481 to access the c...
(Date:11/6/2009)...PRNewswire-FirstCall/ -- Boston Scientific Corpora...ched an agreement in principle with the U.S. Depar...es issued by its Guidant subsidiary in 2005. The ...o Boston Scientific,s 2006 acquisition of Guidant....an investigation by the U.S. Attorney,s Office in ...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 1Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 2Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 3Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 4Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 5Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 6Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 7Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 8Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 9Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 10Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 11Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 12Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 13Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 14Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 15Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 16Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 17Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 18Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 19SCAI Opposes U S House of Representatives Health Reform Bill in Current Form 52988 1SCAI Opposes U S House of Representatives Health Reform Bill in Current Form 52988 2SCAI Opposes U S House of Representatives Health Reform Bill in Current Form 52988 3Martek to Present at Upcoming Canaccord Adams Conference 52983 1
...y, VOORHEES, N.J., Aug. 14 Cytomegalovirus (CMV)... in recipients of hematopoietic,stem cell transpla...e are,serious and range from gastrointestinal dise...n, retinitis, and encephalitis., In order to prev...it is,vital that healthcare professionals involved...
...g clinical benefit in cancer,patients; Blinatumoma...tack cancer cells, B...TI ), a biopharmaceutical company developing novel...er, inflammation and autoimmune,diseases, today an... on its,BiTE(R) antibody blinatumomab (MT103/MEDI-...
Other Medicine Technology:CMV Disease in Stem Cell Transplantation: Prevention and Drug Resistance 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 3Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 4Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 5Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 6
AccuSeed Table Mount Stabilizer
SurePoint™ Stepper/Stabilizer EquipmentPortable
Prospera® Pd-103 Seeds
... BladderChek Test is the only in-office test appro.... The NMP22 BladderChek Test is a painless and non...e, that detects elevated levels of NMP22 protein. ...nts of NMP22 protein in the urine. However, the le...
Medicine Products: